Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysis

Affiliations

• ¹ The Hospital for Sick Children, Toronto, ON, Canada.
• ² Indiana Hemophilia & Thrombosis Center, Inc, Indianapolis, IN, USA.
• ³ Center For Inherited Blood Disorders, Orange, CA, USA.
• ⁴ University of Michigan, Ann Arbor, MI, USA.
• ⁵ University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH, USA.
• ⁶ Walter Reed National Military Medical Center, Bethesda, MD, USA.
• ⁷ University of Iowa Stead Family Children's Hospital, Iowa City, IA, USA.
• ⁸ University of Alberta Stollery Children's Hospital, Edmonton, AB, Canada.
• ⁹ University of Alberta Hospital, Edmonton, AB, Canada.
• ¹⁰ Rady Children's Hospital, San Diego, CA, USA.
• ¹¹ Hemophilia and Thrombosis Center, University of Colorado, Aurora, CO, USA.
• ¹² IWK Health Centre, Halifax, NS, Canada.
• ¹³ Alberta Children's Hospital, Calgary, AB, Canada.
• ¹⁴ Sanofi, Waltham, MA, USA.
• ¹⁵ Trinity Partners LLC, Waltham, MA, USA.
• ¹⁶ Sanofi, Cambridge, MA, USA.